Back to search

Article

Tumor glycosylation engages CD301b-mediated myeloid regulation in breast cancer

2026-05-05

Abstract excerpt

<title>Abstract</title> <p> Aberrant tumor glycosylation can alter immune recognition; however, the specific influence of glycan-lectin interactions on tumor progression remains poorly understood. Here, we identify the C-type lectin receptor CD301b (encoded by <italic>Mgl2</italic> ) as a regulator of immune activity within the breast tumor microenvironment (TME) and identify a cross-species myeloid regulatory...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
89a0af2d-02bd-5cea-82c7-78f36d6a17b8
DOI
10.21203/rs.3.rs-9347231/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Tumor glycosylation engages CD301b-mediated myeloid regulation in breast cancerDOI 10.21203/rs.3.rs-9347231/v1
Select a neighboring publication to make it the new centre.